The increasing prevalence of oncology-related conditions and the global push for early intervention are driving a transformative era in medical imaging and molecular testing. The Breast Cancer Diagnostics Market was valued at USD 4.89 billion in 2024 and is expected to reach USD 10.33 billion by 2032, growing at a robust CAGR of 12.71% during the forecast...